Professional Documents
Culture Documents
8/17/13 4:39 AM
Hub
ScienceDirect
Scopus
Applications
Register
Login
Go to SciVal Suite
Search
Sources
Analytics
Alerts
Search
My list
Settings
Live Chat
Help
Tutorials
Quick Search
Back to results | 1 of 1
| Molecular Pharmaceutics
| View at Publisher |
Export
Create bibliography
Add to My List
( Review )
Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability
(2013) Colloids and Surfaces B: Biointerfaces Nambiar, D. , Singh, R.P.
Cytokine Research Laboratory, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, United
States
b
Pharmaceutical Development Center, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030,
United States
c
Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Box 143, 1515 Holcombe Blvd, Houston, TX 77030, United
View details of all 594 citations Inform me when this document is cited in Scopus:
Set alert | Set feed
Abstract
Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including antiinflammatory, antioxidant, antiproliferative and antiangiogenic activities. Phase I clinical trials have shown that curcumin is safe even at high doses (12 g/day) in humans but exhibit poor bioavailability. Major reasons contributing to the low plasma and tissue levels of curcumin appear to be due to poor absorption, rapid metabolism, and rapid systemic elimination. To improve the bioavailability of curcumin, numerous approaches have been undertaken. These approaches involve, first, the use of adjuvant like pipeline that interferes with glucuronidation; second, the use of liposomal curcumin; third, curcumin nanoparticles; fourth, the use of curcumin phospholipid complex; and fifth, the use of structural analogues of curcumin (e.g., EF-24). The latter has been reported to have a rapid absorption with a peak plasma half-life. Despite the lower bioavailability, therapeutic efficacy of curcumin against various human diseases, including cancer, cardiovascular diseases, diabetes, arthritis, neurological diseases and Crohn's disease, has been documented. Enhanced bioavailability of curcumin in the near future is likely to bring this promising natural product to the forefront of therapeutic agents for treatment of human disease. 2007 American Chemical Society.
Find more related documents in Scopus based on: Authors | Keywords
Related documents
Author keywords
Absorption; Adjuvants; Bioavailability; Biocurcumax; Curcumin; Formulations; Metabolism; Nanoparticles
Indexed keywords
EMTREE drug terms: antineoplastic agent; biocurcumax; boron; cadmium; copper; curcumin; curcumin glucuronide derivative; dihydrocurcumin; ef 24; epigallocatechin gallate; eugenol; gallium; genistein; glucuronide; hexahydrocurcumin; indium; liposome; manganese; nanoparticle; oxaliplatin; phospholipid; piperine; placebo; quercetin; terpene derivative; terpeneol; tetrahydrocurcumin; unclassified drug; vanadyl derivative EMTREE medical terms: adenomatous polyp; adjuvant therapy; area under the curve; arthritis; carcinoma cell; cardiovascular disease; clinical trial; colorectal cancer; combination chemotherapy; complex formation; Crohn disease; diabetes mellitus; drug absorption; drug bioavailability; drug blood level; drug dosage form comparison; drug efficacy; drug elimination; drug half life; drug megadose; drug metabolism; drug potentiation; drug structure; drug tissue level; glucuronidation; human; micelle; monotherapy; neoplasm; neurologic disease; nonhuman; priority journal; review; single drug dose; unspecified side effect MeSH: Animals; Biological Availability; Curcumin; Drug Delivery Systems; Humans; Tissue Distribution Medline is the source for the MeSH terms of this document. Chemicals and CAS Registry Numbers: boron, 7440-42-8; cadmium, 22537-48-0, 7440-43-9; copper, 15158-11-9, 7440-50-8; curcumin, 458-37-7; epigallocatechin gallate, 989-51-5; eugenol, 97-53-0; gallium, 7440-55-3; genistein, 446-72-0; indium, 7440-746; manganese, 16397-91-4, 7439-96-5; oxaliplatin, 61825-94-3; piperine, 94-62-2; quercetin, 117-39-5;Curcumin, 458-37-7 Drug tradename: ef 24.
ISSN: 15438384 Source Type: Journal Original language: English Document Type: Review View in table layout
DOI: 10.1021/mp700113r
References (85)
First 80 references displayed (View all references)
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 1 of 9
8/17/13 4:39 AM
Page
Export
Create bibliography
Sharma, O.P.
2
Ruby, A.J., Kuttan, G., Dinesh Babu, K., Rajasekharan, K.N., Kuttan, R.
3
Mahady, G. B.; Pendland, S. L.; Yun, G; Lu, Z. Z. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter 7 pylori, a group 1 carcinogen. Anticancer Res. 2002, 22 (6C), 4179-81.
Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse
(2003) Journal of Agricultural and Food Chemistry, 51 (6), pp. 1578-1581. Cited 54 times. doi: 10.1021/jf0210369
View at Publisher
Reddy, R.C., Vatsala, P.G., Keshamouni, V.G., Padmanaban, G., Rangarajan, P.N.
9
Venkatesan, N.Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br. J. Pharmacol. 1998, 124 (3), 425-7. 12
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 2 of 9
8/17/13 4:39 AM
Prevention of ischaemia-induced biochemical changes by curcumin and quinidine in the cat heart
(1995) Indian Journal of Medical Research, 101 (JAN.), pp. 31-35. Cited 58 times.
Srinivasan, M.
18
Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat
(1995) Molecular and Cellular Biochemistry, 152 (1), pp. 13-21. Cited 53 times.
Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats
(1997) Molecular and Cellular Biochemistry, 166 (1-2), pp. 169-175. Cited 137 times. doi: 10.1023/A:1006819605211
View at Publisher
Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats
(2002) Plant Foods for Human Nutrition, 57 (1), pp. 41-52. Cited 135 times. doi: 10.1023/A:1013106527829
View at Publisher
Shankar, T.N., Shantha, N.V., Ramesh, H.P., Murthy, I.A., Murthy, V.S.
23
Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs & monkeys
(1980) Indian Journal of Experimental Biology, 18 (1), pp. 73-75. Cited 80 times.
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 3 of 9
8/17/13 4:39 AM
doi: 10.1586/14737140.6.11.1559
View at Publisher
Lao, C.D., Ruffin IV, M.T., Normolle, D., Heath, D.D., Murray, S.I., Bailey, J.M., Boggs, M.E., (...), Brenner, D.E.
26
doi: 10.1186/1472-6882-6-10
View at Publisher
Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming-Shiang, W; Yu, H. 27 S.; Jee, S. H.; Chen, G. S.; Chen, T. M.; Chen, C. A.; Lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.; Hsieh, C. Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21 (4B), 2895-900.
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., Srinivas, P.S.S.R.
28
Perkins, S., Verschoyle, R.D., Hill, K., Parveen, I., Threadgill, M.D., Sharma, R.A., Williams, M.L., (...), Gescher, A.J.
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 4 of 9
8/17/13 4:39 AM
35
Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis
(2002) Cancer Epidemiology Biomarkers and Prevention, 11 (6), pp. 535-540. Cited 154 times.
View at Publisher
Sharma, R. A.; Euden, S. A.; Platten, S. L.; Cooke, D. N.; Shafayat, A; Hewitt, H. R.; Marczylo, T. H.; Morgan, B.; Hemingway, 36 D.; Plummer, S. M.; Pirmohamed, M; Gescher, A. J.; Steward, W. P. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 2004, 10 (20), 6847-54.
Yang, K.-Y., Lin, L.-C., Tseng, T.-Y., Wang, S.-C., Tsai, T.-H.
37
Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS
(2007) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 853 (1-2), pp. 183189. Cited 80 times. doi: 10.1016/j.jchromb.2007.03.010
View at Publisher
Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P., Mukherjee, P.K.
38
Marczylo, T. H.; Verschoyle, R. D.; Cooke, D. N.; Morazzoni, P; Steward, W. P.; Gescher, A. J. Comparison of systemic 39 availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother. Pharmacol. 2007, 60 (2), 171-7.
Garcea, G., Jones, D.J.L., Singh, R., Dennison, A.R., Farmer, P.B., Sharma, R.A., Steward, W.P., (...), Berry, D.P.
41
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
(2004) British Journal of Cancer, 90 (5), pp. 1011-1015. Cited 162 times. doi: 10.1038/sj.bjc.6601623
View at Publisher
Garcea, G., Berry, D.P., Jones, D.J.L., Singh, R., Dennison, A.R., Farmer, P.B., Sharma, R.A., (...), Gescher, A.J.
42
Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences
(2005) Cancer Epidemiology Biomarkers and Prevention, 14 (1), pp. 120-125. Cited 156 times.
View at Publisher
Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver
(2006) Journal of Agricultural and Food Chemistry, 54 (3), pp. 756-764. Cited 37 times. doi: 10.1021/jf058146a
View at Publisher
Ireson, C., Orr, S., Jones, D.J.L., Verschoyle, R., Lim, C.-K., Luo, J.-L., Howells, L., (...), Gescher, A.
45
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production
(2001) Cancer Research, 61 (3), pp. 1058-1064. Cited 226 times.
View at Publisher
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 5 of 9
8/17/13 4:39 AM
46
Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma
(2000) Life Sciences, 67 (23), pp. 2785-2793. Cited 89 times.
View at Publisher
Sandur, S.K., Pandey, M.K., Sung, B., Ahn, K.S., Murakami, A., Sethi, G., Limtrakul, P., (...), Aggarwal, B.B.
48
Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism
(2007) Carcinogenesis, 28 (8), pp. 1765-1773. Cited 118 times. doi: 10.1093/carcin/bgm123
View at Publisher
Pfeiffer, E., Hoehle, S.I., Walch, S.G., Riess, A., Slyom, A.M., Metzler, M.
49
Kim, J.M., Araki, S., Kim, D.J., Park, C.B., Takasuka, N., Baba-Toriyama, H., Ota, T., (...), Tsuda, H.
50
Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2dimethylhydrazine initiation
(1998) Carcinogenesis, 19 (1), pp. 81-85. Cited 165 times. doi: 10.1093/carcin/19.1.81
View at Publisher
Okada, K., Wangpoengtrakul, C., Tanaka, T., Toyokuni, S., Uchida, K., Osawa, T.
51
Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice
(2001) Journal of Nutrition, 131 (8), pp. 2090-2095. Cited 108 times.
View at Publisher
Naito, M., Wu, X., Nomura, H., Kodama, M., Kato, Y., Kato, Y., Osawa, T.
52
Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats
(2005) Journal of Pharmacy and Pharmaceutical Sciences, 8 (1), pp. 115-123. Cited 47 times.
http://www.ualberta.ca/~csps/JPPS8(1)/L.Pari/thc.htm View at Publisher
55
Sharma, R.A., McLelland, H.R., Hill, K.A., Ireson, C.R., Euden, S.A., Manson, M.M., Pirmohamed, M., (...), Steward, W.P. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer
(2001) Clinical Cancer Research, 7 (7), pp. 1894-1900. Cited 305 times.
View at Publisher
Ryu, E.K., Choe, Y.S., Lee, K.-H., Choi, Y., Kim, B.-T.
56
Curcumin and dehydrozingerone derivatives: Synthesis, radiolabeling, and evaluation for -amyloid plaque imaging
(2006) Journal of Medicinal Chemistry, 49 (20), pp. 6111-6119. Cited 62 times. doi: 10.1021/jm0607193
View at Publisher
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 6 of 9
8/17/13 4:39 AM
Cruz-Correa, M., Shoskes, D.A., Sanchez, P., Zhao, R., Hylind, L.M., Wexner, S.D., Giardiello, F.M.
57
Combination Treatment With Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis
(2006) Clinical Gastroenterology and Hepatology, 4 (8), pp. 1035-1038. Cited 110 times. doi: 10.1016/j.cgh.2006.03.020
View at Publisher
Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides
(1997) Biochemical and Biophysical Research Communications, 233 (3), pp. 692-696. Cited 74 times. doi: 10.1006/bbrc.1997.6527
View at Publisher
Fang, J.Y., Hung, C.F., Chiu, H.C., Wang, J.J., Chan, T.F.
59
Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
(2003) The Journal of pharmacy and pharmacology, 55 (8), p. 1175. Cited 7 times.
View at Publisher
Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function
(2004) Journal of Biological Chemistry, 279 (23), pp. 24007-24014. Cited 45 times. doi: 10.1074/jbc.M314331200
View at Publisher
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., Maitra, A.
61
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): A novel strategy for human cancer therapy
(2007) Journal of Nanobiotechnology, 5, art. no. 3. Cited 248 times. doi: 10.1186/1477-3155-5-3
View at Publisher
Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis
(2005) Cancer, 104 (6), pp. 1322-1331. Cited 195 times. doi: 10.1002/cncr.21300
View at Publisher
Liposomal curcumin with and without oxaliplatin: Effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
(2007) Molecular Cancer Therapeutics, 6 (4), pp. 1276-1282. Cited 102 times. doi: 10.1158/1535-7163.MCT-06-0556
View at Publisher
Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study
(2006) Biochimica et Biophysica Acta - General Subjects, 1760 (10), pp. 1513-1520. Cited 88 times. doi: 10.1016/j.bbagen.2006.06.012
View at Publisher
Studies on the in vitro absorption of spice principles - Curcumin, capsaicin and piperine in rat intestines
(2007) Food and Chemical Toxicology, 45 (8), pp. 1437-1442. Cited 39 times. doi: 10.1016/j.fct.2007.02.002
View at Publisher
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 7 of 9
8/17/13 4:39 AM
High-performance liquid chromatography analysis of curcumin in rat plasma: Application to pharmacokinetics of polymeric micellar formulation of curcumin
(2007) Biomedical Chromatography, 21 (5), pp. 546-552. Cited 60 times. doi: 10.1002/bmc.795
View at Publisher
Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers
(1994) International Journal of Clinical Pharmacology and Therapeutics, 32 (11), pp. 614-617. Cited 56 times.
Kimura, T., Takeda, K., Kageyu, A., Toda, M., Kurosaki, Y., Nakayama, T.
69
Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin
(2006) Journal of Pharmaceutical and Biomedical Analysis, 40 (3), pp. 720-727. Cited 73 times. doi: 10.1016/j.jpba.2005.09.032
View at Publisher
Ohori, H., Yamakoshi, H., Tomizawa, M., Shibuya, M., Kakudo, Y., Takahashi, A., Takahashi, S., (...), Shibata, H.
75
Synthesis and biolgical analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
(2006) Molecular Cancer Therapeutics, 5 (10), pp. 2563-2571. Cited 66 times. doi: 10.1158/1535-7163.MCT-06-0174
View at Publisher
Sui, Z., Salto, R., Li, J., Craik, C., Ortiz de Montellano, P.R.
77
Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes
(1993) Bioorganic and Medicinal Chemistry, 1 (6), pp. 415-422. Cited 92 times.
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 8 of 9
8/17/13 4:39 AM
View at Publisher
The influence of curcumin and manganese complex of curcumin on cadmium-induced oxidative damage and trace elements status in tissues of mice
(2006) Journal of Applied Toxicology, 26 (3), pp. 207-212. Cited 20 times. doi: 10.1002/jat.1124
View at Publisher
Vajragupta, O., Boonchoong, P., Watanabe, H., Tohda, M., Kummasud, N., Sumanont, Y.
79
Manganese complexes of curcumin and its derivatives: Evaluation for the radical scavenging ability and neuroprotective activity
(2003) Free Radical Biology and Medicine, 35 (12), pp. 1632-1644. Cited 81 times. doi: 10.1016/j.freeradbiomed.2003.09.011
View at Publisher
Manganese complexes of curcumin analogues: Evaluation of hydroxyl radical scavenging ability, superoxide dismutase activity and stability towards hydrolysis
(2004) Free Radical Research, 38 (3), pp. 303-314. Cited 41 times. doi: 10.1080/10715760310001643339
View at Publisher
First 80 references displayed (View all references) Aggarwal, B.B.; Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Box 143, 1515 Holcombe Blvd, Houston, TX 77030, United States; email:aggarwal@mdanderson.org Copyright 2009 Elsevier B.V., All rights reserved. MEDLINE is the source for the MeSH terms of this document.
Back to results | 1 of 1
Top of page
Language Customer Service Contact and support Live Chat About Elsevier Terms and Conditions Privacy Policy
Copyright 2013 Elsevier B.V. All rights reserved. SciVerse is a registered trademark of Elsevier Properties S.A., used under license. Scopus is a registered trademark of Elsevier B.V. Cookies are set by this site. To decline them or learn more, visit our Cookies page.
https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29
Page 9 of 9